SCHEMBL24896264

SCHEMBL24896264

CC(C)N(C)C(=O)c1cc2ccnc(Cl)c2n1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 3/20 0.39
▸ CDC7 O00311 1/20 0.31
▸ PLK4 O00444 1/20 0.31
▸ AURKA O14965 1/20 0.31
▸ ROCK2 O75116 1/20 0.31
▸ RPS6KA5 O75582 1/20 0.31
▸ MAP4K4 O95819 1/20 0.31
▸ PRKCG P05129 1/20 0.31
▸ CDK1 P06493 1/20 0.31
▸ PIM1 P11309 1/20 0.31
▸ PRKACA P17612 1/20 0.31
▸ RPS6KB1 P23443 1/20 0.31
▸ CDK2 P24941 1/20 0.31
▸ AKT1 P31749 1/20 0.31
▸ GSK3A P49840 1/20 0.31
▸ GSK3B P49841 1/20 0.31
▸ IRAK1 P51617 1/20 0.31
▸ RPS6KA3 P51812 1/20 0.31
▸ PRKX P51817 1/20 0.31
▸ JAK3 P52333 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20504453 0.79 MCL1 (0.45) SYKRXFP1ALDH1A1MAPT
SCHEMBL24896265 0.78 MAPT (0.46) ALDH1A1MAPT
SCHEMBL24896276 0.76 SYK (0.36) SYK
SCHEMBL20504325 0.76 L3MBTL1 (0.47) SYKALDH1A1MAPTL3MBTL1
SCHEMBL25003511 0.76 SYK (0.35) SYK
SCHEMBL24896271 0.74 PHGDH (0.41) SYKALDH1A1
SCHEMBL30220535 0.73 JMJD6 (0.41) ALDH1A1MAPT
SCHEMBL24896282 0.73 TP53 (0.41) RXFP1MAPT
SCHEMBL24896378 0.70 ALDH1A1 (0.38) ALDH1A1L3MBTL1
SCHEMBL23478374 0.70 RXFP1 (0.34) RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240368137-A1 BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES, INC. 2024-11-07 — — US disclosed
EP-4370207-A1 BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS Nido Biosciences, Inc. (US) 2024-05-22 — — EP disclosed
US-20230039586-A1 BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES, INC. 2023-02-09 — — US disclosed
WO-2023287704-A1 BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES, INC. (US) 2023-01-19 — — WO disclosed
WO-2023287704-A1 BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES, INC. (US) 2023-01-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230039586-A1 BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS AR, FSHR, NR5A1 SYK 4883/4885CDC7 3221/4885PLK4 2178/4885
US-20240368137-A1 BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS AR, FSHR, NR5A1 SYK 4883/4885CDC7 3221/4885PLK4 2178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback